Creating cell banks for vaccine development to prepare for pandemics
Official title: Task V26: MASTER CELL BANKS MANUFACTURING FOR PANDEMIC PREPAREDNESS
Funded at Idt Biologika Gmbh · NIH-10168827 · Data updated 2026-11-12
This study is all about creating special cell banks that help make vaccines quicker and safer for fighting infectious diseases and potential bioterrorism threats, so we can respond better to health emergencies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Idt Biologika Gmbh NIH-funded |
| Lab location | 1 site (Dessau-Rosslau, Germany) |
| Project start | May 15, 2018 |
| Project end | May 14, 2028 |
| Funding year | 2020 |
| Award (this year) | $20,462 |
| NIH project number | 272201800011I-0-759302000002-1 |
| Project ID | NIH-10168827 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals at risk of infectious diseases or those living in areas prone to outbreaks.
✕Less likely to help
Patients who are not at risk for infectious diseases or who have contraindications to vaccination may not benefit from this research.
What this research studies
This research focuses on the manufacturing and characterization of cell banks that are essential for developing vaccines against infectious diseases and potential bioterrorism threats. It involves planning and optimizing vaccine production, ensuring compliance with regulatory standards, and conducting necessary audits. By establishing these cell banks, the project aims to streamline the process of vaccine development, making it faster and more efficient in response to emerging health threats.
Why it matters
Potential benefit: If successful, this research could lead to the rapid development of effective vaccines during pandemics, ultimately saving lives.
How similar studies have gone: Previous research has shown success in vaccine development using similar manufacturing approaches, indicating a promising path forward.
Where this research is happening
-
Idt Biologika Gmbh
Dessau-Rosslau, Germany Active
Researchers
- Principal investigator: Neubert, Andreas — Idt Biologika Gmbh
- Study coordinator: Neubert, Andreas
Related research
Other NIH-funded projects on the same topics.
-
Developing new vaccines for infectious diseases and bioterrorism
This study is all about creating new vaccines to help protect people from infectious diseases, including those that could come from bioterrorism or drug-resistant germs, so that patients can have better options for staying healthy.
-
Creating master cell banks for new SARS-CoV-2 vaccines
This study is working on creating special cell banks to help make better vaccines for COVID-19, which could lead to more effective options for patients in the future.
-
Creating materials for testing new influenza vaccines
This study is working on creating and improving materials for new flu vaccines, which could help keep you and others safer from the flu and similar illnesses.
-
Creating master cell banks for new SARS-CoV-2 vaccines
This study is working on creating special cell banks to help make better vaccines for COVID-19, so that patients can have more effective protection against the virus and its variants.
-
Creating vaccines and biologics to combat infectious diseases
This study is working on creating new vaccines to help protect people from infections like those caused by E. coli, so that patients can have better options for staying healthy and safe from serious diseases.
-
Developing a vaccine for Staphylococcus aureus
This study is working on creating a new vaccine to help protect people from Staphylococcus aureus infections, which can be tough to treat because the bacteria resist many antibiotics, and it aims to make this vaccine safe and effective for future use.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.